Exponent
Search documents
Exponent (EXPO) Upgraded to Buy: Here's What You Should Know
ZACKS· 2026-02-09 18:00
Exponent (EXPO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a ...
Exponent (EXPO) Tops Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-05 23:50
Exponent (EXPO) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.70%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.5 per share when it actually produced earnings of $0.55, delivering a surprise of +10%.Over the last ...
Exponent(EXPO) - 2025 Q4 - Earnings Call Transcript
2026-02-05 22:32
Financial Data and Key Metrics Changes - Total revenues for Q4 2025 increased by 8% to $147.4 million, while net revenues rose by 5% to $129.4 million compared to Q4 2024 [12][13] - Net income for Q4 was $24.8 million, or $0.49 per diluted share, up from $23.6 million, or $0.46 per diluted share in the prior year [14] - EBITDA for Q4 was $34.7 million, with a margin of 26.8% of net revenues, compared to $31.2 million or 25.2% in the same period of 2024 [15] - For the full year 2025, total revenues grew by 4% to $582 million, while net revenues increased to $536.8 million [18] - Net income for the year decreased by 3% to $106 million, or $2.07 per diluted share [18] Business Line Data and Key Metrics Changes - The engineering and other scientific segment represented 85% of net revenues in Q4 2025, with a 7% increase in net revenues for the quarter and a 4% increase for the full year [22] - The environmental and health segment accounted for 15% of net revenue in Q4, with a 5% decrease in revenues for the quarter, while remaining flat for the full year [23] Market Data and Key Metrics Changes - Growth in proactive engagements was driven by increased demand in user research and consumer electronics, as well as risk management work in the utility sector [4][5] - Reactive engagements saw growth due to failure analysis and dispute-related services across various industries, including energy and transportation [7] Company Strategy and Development Direction - The company aims to leverage artificial intelligence and complex technologies to enhance its service offerings and maintain a competitive edge [10][30] - Exponent is focused on diversifying its client base and product offerings, particularly in the consumer electronics and energy sectors [11][46] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the demand environment, particularly in AI and novel technologies, which are expected to drive growth in 2026 [36][39] - The company anticipates high single-digit growth in net revenues for Q1 and full year 2026, with EBITDA margins expected to remain stable [24][28] Other Important Information - The company distributed $61.5 million to shareholders through dividends and repurchased $97.8 million of common stock in 2025 [21] - As of year-end, Exponent had $221.9 million in cash and cash equivalents [22] Q&A Session Summary Question: Performance of consumer electronics in proactive business - Management noted an uptick in user research engagements, particularly related to health-related products and novel AI-driven devices [33][34] Question: Guidance and visibility for 2026 - Management indicated strong visibility into market demands and trends, with a positive outlook for headcount growth and utilization [36][39] Question: Characterization of 2026 compared to 2025 - Management highlighted an acceleration of growth and demand across various sectors, particularly in consumer electronics and energy [44][46] Question: AI's impact on litigation support and investigation services - Management discussed the integration of AI tools to enhance efficiency while also emphasizing the need for high-level expertise to handle complex data [50][52] Question: Expectations for net headcount growth in 2026 - Management expects net headcount growth of 40-50, focusing on areas such as transportation, energy, and cybersecurity [56][58] Question: AI's contribution to growth - Management affirmed that AI is a net benefit, driving growth in various sectors, including transportation and user research [60][68]
Exponent(EXPO) - 2025 Q4 - Earnings Call Transcript
2026-02-05 22:32
Exponent (NasdaqGS:EXPO) Q4 2025 Earnings call February 05, 2026 04:30 PM ET Company ParticipantsCatherine Corrigan - President and CEOJoni Konstantelos - Managing DirectorJosh Chan - Executive DirectorRich Schlenker - EVP and CFOTobey Sommer - Managing DirectorTomo Sano - Managing DirectorConference Call ParticipantsAndrew Nicholas - Equity Research AnalystOperatorGood day, and welcome to the Exponent, Inc. Fourth Quarter and Fiscal Year 2025 earnings conference call. All participants will be in listen-onl ...
Exponent(EXPO) - 2025 Q4 - Earnings Call Transcript
2026-02-05 22:30
Exponent (NasdaqGS:EXPO) Q4 2025 Earnings call February 05, 2026 04:30 PM ET Speaker2Good day, and welcome to the Exponent, Inc. fourth quarter and fiscal year 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press Star then One on a touchtone phone. To withdraw your quest ...
Exponent(EXPO) - 2025 Q4 - Earnings Call Presentation
2026-02-05 21:30
1 Forward Looking Statements & Non-GAAP Financial Measures This presentation release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Com ...
Exponent(EXPO) - 2025 Q4 - Annual Results
2026-02-05 21:05
EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results Total revenues increased 4.2% to $582.0 million during the 52-week fiscal year 2025, as compared to $558.5 million during the 53-week fiscal year 2024. Revenues before reimbursements increased 3.5% to $536.8 million, compared to $518.5 million in fiscal year 2024. Net income was $106.0 million, or $2.07 per diluted share, during fiscal year 2025, as compared to $109.0 million, or $2.11 per diluted share, in fiscal year 2024. ...
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026
Globenewswire· 2026-02-05 21:05
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.30 to $0.31 per share of common stock. The quarterly cash dividend of $0.31 per share of common stock is to be paid on March 20, 2026 to all common stockholders of record as of March 6, 2026. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of ...
Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Globenewswire· 2026-02-05 21:05
MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026. “We delivered a strong finish to 2025 reflecting the strength, diversification, and resilience of our portfolio,” stated Dr. Catherine Corrigan, President and Chief Executive Officer. “Growth in proactive engagements during the fourth quarter was driven by increased demand for user research services in the consumer electronics ...
Xeinadin auction pulled after buyers reject £1bn valuation
Yahoo Finance· 2026-02-02 11:40
Core Viewpoint - The sale of UK accountancy practice Xeinadin has been paused due to bids falling short of the £1 billion ($1.36 billion) valuation sought by its private equity owner, Exponent [1][2]. Group 1: Sale Process and Valuation - Exponent initiated a competitive auction for Xeinadin but ended the sale effort as the interest did not translate into offers meeting the expected valuation [2]. - The abandoned sale process indicates potential valuation constraints in the recent boom of private equity deals for professional services businesses [2]. Group 2: Industry Trends - Accounting networks in the US, UK, and Europe have seen increased interest from buyout funds, leading to higher deal multiples as investors pursue a buy-and-build strategy [3]. - Many investors have been acquiring local tax and accounting firms to standardize systems and invest in technology, aiming to enhance margins and attract larger clients [3]. Group 3: Company Overview - Xeinadin was established in 2019 through the merger of over 100 independent accounting practices and has continued to grow through additional acquisitions [4]. - The company operates more than 130 offices in the UK and Ireland, employing around 2,500 staff and providing a range of professional services including audit, corporate finance, and tax to small and medium-sized businesses [4][5]. - Recently, Xeinadin expanded its presence in London by acquiring Grunberg [5].